Trial Profile
Study of rivaroxaban and intracranial haemorrhage after mild traumatic brain injury
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2016
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Intracranial haemorrhages; Traumatic brain injuries
- Focus Adverse reactions; Therapeutic Use
- 22 Dec 2016 New trial record